TET2 and acute myeloid leukemia: Considering the recurrently mutated genes TP53, FLT3, NPM1, DNMT3A, TET2, RUNX1, IDH1, IDH2 in AML, we found a statistically significant association between TP53 mutated samples and a lower expression of TAS2R9 (p-value = 0.008) and TAS2R10 (p-value = 0.03) and between TET2 mutated samples and a lower expression of TAS2R9 (p-value = 0.04) (Figures 2A,B).